Document is current
Any future updates will be listed below
-
Authors
Navarro, Isabela Cunha https://orcid.org/0000-0002-6844-2361
Tuorto, Francesca https://orcid.org/0000-0003-1625-1181
Jordan, David
Legrand, Carine
Price, Jonathan
Braukmann, Fabian
Hendrick, Alan G
Akay, Alper
Kotter, Annika
Helm, Mark
Lyko, Frank
Miska, Eric A https://orcid.org/0000-0002-4450-576X
-
Funding
Funding for this research was provided by:
MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (205589/2014‐6)
Cancer Research UK (C13474/A27826)
Cancer Research UK (C6946/A24843)
The Wellcome Trust (104640/Z/14/Z)
The Wellcome Trust (092096/Z/10/Z)
The Wellcome Trust (203144/Z/16/Z)
Deutsche Forschungsgemeinschaft (SPP1784)
- License Information
-
More Information
Article History
Received: 2 May 2020
Revised: 4 November 2020
Accepted: 10 November 2020
First Online: 7 December 2020
Conflict of interest
: E.A.M. is a co‐founder and director of Storm Therapeutics, Cambridge, UK. A.H. is an employee of Storm Therapeutics, Cambridge, UK.
